Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress

Aging

Volumn 9, Issue 6, 2017, Pages 1595-1606

  Dinh, Quynh Nhu ^a,d   Drummond, Grant R ^a,b,d   Kemp Harper, Barbara K ^a   Diep, Henry ^a,b,d   De Silva, T Michael ^a,d   Kim, Hyun Ah ^a,d   Vinh, Antony ^a,b,d   Robertson, Avril A B ^c   Cooper, Matthew A ^c   Mansell, Ashley ^f   Chrissobolis, Sophocles ^a,e   Sobey, Christopher G ^a,b,d  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e OHIO NORTHERN UNIVERSITY   (United States)

^f HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Aging; Angiotensin II; Hypertension; Inflammation; Oxidative stress; Vasoconstriction

Indexed keywords

ANGIOTENSIN II; BIOLOGICAL MARKER;

AGING; ANIMAL; BLOOD; BLOOD PRESSURE; BRAIN; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; INFLAMMATION; KIDNEY; MALE; MESENTERIC ARTERY; METABOLISM; MOUSE; OXIDATIVE STRESS; PHYSIOLOGY; VASOCONSTRICTION;

AGING; ANGIOTENSIN II; ANIMALS; BIOMARKERS; BLOOD PRESSURE; BRAIN; GENE EXPRESSION REGULATION; INFLAMMATION; KIDNEY; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; VASOCONSTRICTION;

EID: 85021761128     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.101255     Document Type: Article

References (29)

1. van Rossum CT, van de Mheen H, Witteman JC, Hofman A, Mackenbach JP, Grobbee DE. Prevalence, treatment, and control of hypertension by sociodemographic factors among the Dutch elderly. Hypertension. 2000; 35:814-21. doi: 10. 1161/01. HYP. 35. 3. 814
2. Dinh QN, Chrissobolis S, Diep H, Chan CT, Ferens D, Drummond GR, Sobey CG. Advanced atherosclerosis is associated with inflammation, vascular dysfunction and oxidative stress, but not hypertension. Pharmacol Res. 2017; 116:70-76. doi: 10. 1016/j. phrs. 2016. 12. 032
3. Mirabito KM, Hilliard LM, Head GA, Widdop RE, Denton KM. Pressor responsiveness to angiotensin II in female mice is enhanced with age: role of the angiotensin type 2 receptor. Biol Sex Differ. 2014; 5:13. doi: 10. 1186/s13293-014-0013-7
4. Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. BioMed Res Int. 2014; 2014:406960. doi: 10. 1155/2014/406960
5. Chan CT, Sobey CG, Lieu M, Ferens D, Kett MM, Diep H, Kim HA, Krishnan SM, Lewis CV, Salimova E, Tipping P, Vinh A, Samuel CS, et al. Obligatory role for B cells in the development of Angiotensin II-dependent hypertension. Hypertension. 2015; 66:1023-33. doi: 10. 1161/HYPERTENSIONAHA. 115. 05779
6. Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR. IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol. 2014; 171:5589-602. doi: 10. 1111/bph. 12876
7. Krishnan SM, Dowling JK, Ling YH, Diep H, Chan CT, Ferens D, Kett MM, Pinar A, Samuel CS, Vinh A, Arumugam TV, Hewitson TD, Kemp-Harper BK, et al. Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice. Br J Pharmacol. 2016; 173:752-65. doi: 10. 1111/bph. 13230
8. Song F, Ma Y, Bai XY, Chen X. The expression changes of inflammasomes in the aging rat kidneys. J Gerontol A Biol Sci Med Sci. 2016; 71:747-56. doi: 10. 1093/gerona/glv078
9. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol. 2002; 13:2860-68. doi: 10. 1097/01. ASN. 0000035087. 11758. ED
10. Zhou Y, Chen Y, Dirksen WP, Morris M, Periasamy M. AT1b receptor predominantly mediates contractions in major mouse blood vessels. Circ Res. 2003; 93:1089-94. doi: 10. 1161/01. RES. 0000101912. 01071. FF
11. Crowley SD, Gurley SB, Coffman TM. AT(1) receptors and control of blood pressure: the kidney and more. Trends Cardiovasc Med. 2007; 17:30-34. doi: 10. 1016/j. tcm. 2006. 11. 002
12. Zhang H, Schmeisser A, Garlichs CD, Plötze K, Damme U, Mügge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res. 1999; 44:215-22. doi: 10. 1016/S0008-6363(99)00183-2
13. Widdop RE, Jones ES, Hannan RE, Gaspari TA. Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol. 2003; 140:809-24. doi: 10. 1038/sj. bjp. 0705448
14. Matrougui K, Loufrani L, Heymes C, Lévy BI, Henrion D. Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension. 1999; 34:659-65. doi: 10. 1161/01. HYP. 34. 4. 659
15. Savoia C, Tabet F, Yao G, Schiffrin EL, Touyz RM. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens. 2005; 23:1037-45. doi: 10. 1097/01. hjh. 0000166845. 49850. 39
16. Kim JM, Uehara Y, Choi YJ, Ha YM, Ye BH, Yu BP, Chung HY. Mechanism of attenuation of pro-inflammatory Ang II-induced NF-κB activation by genistein in the kidneys of male rats during aging. Biogerontology. 2011; 12:537-50. doi: 10. 1007/s10522-011-9345-4
17. Gurantz D, Cowling RT, Varki N, Frikovsky E, Moore CD, Greenberg BH. IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart. J Mol Cell Cardiol. 2005; 38:505-15. doi: 10. 1016/j. yjmcc. 2004. 12. 015
18. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995; 377:748-50. doi: 10. 1038/377748a0
19. Yoon HE, Kim EN, Kim MY, Lim JH, Jang IA, Ban TH, Shin SJ, Park CW, Chang YS, Choi BS. Age-associated changes in the vascular renin-angiotensin system in mice. Oxid Med Cell Longev. 2016; 2016:6731093. doi: 10. 1155/2016/6731093
20. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol. 2007; 292:R18-36. doi: 10. 1152/ajpregu. 00327. 2006
21. Fleenor BS, Seals DR, Zigler ML, Sindler AL. Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice. Aging Cell. 2012; 11:269-76. doi: 10. 1111/j. 1474-9726. 2011. 00783. x
22. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999; 104:925-35. doi: 10. 1172/JCI7886
23. Meyer MR, Fredette NC, Barton M, Prossnitz ER. Endothelin-1 but not angiotensin II contributes to functional aging in murine carotid arteries. Life Sci. 2014; 118:213-18. doi: 10. 1016/j. lfs. 2014. 02. 027
24. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA. 1995; 92:3521-25. doi: 10. 1073/pnas. 92. 8. 3521
25. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014 (Suppl 1); 69:S4-9. doi: 10. 1093/gerona/glu057
26. Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, Rizzo C, Colonna-Romano G, Lio D, Di Carlo D, Palmas MG, Scurti M, Pini E, et al. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des. 2010; 16:609-18. doi: 10. 2174/138161210790883840
27. Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015; 21:248-55
28. Tadevosyan A, Maclaughlin EJ, Karamyan VT. Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes. Patient Relat Outcome Meas. 2011; 2:27-39
29. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3:1101-08. doi: 10. 1038/nprot. 2008. 73